Capital Area Research - Newport is a clinical research site located in Newport, Pennsylvania, United States 17074.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Capital Area Research - Newport has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Type 2 Diabetes, Obesity, Overweight or Obesity.
Sponsors: Eli Lilly and Company.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Capital Area Research - Newport has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Capital Area Research - Newport has 1 clinical trials on record, with 1 currently active. Their work covers Type 2 Diabetes, Obesity, Overweight or Obesity.
Capital Area Research - Newport has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.